Virulence profile of strains of Cryptococcus neoformans var. grubii evaluated by experimental infection in BALB/c mice and correlation with exoenzyme activity

Journal of Medical Microbiology

Volumn 55, Issue 2, 2006, Pages 139-142

  Da Silva, Eriques Gonçalves ^a   Baroni, Francisco De Assis ^b   Viani, Flavio César ^a   Ruiz, Luciana Da Silva ^a   Gandra, Rinaldo Ferreira ^c   Auler, Marcos Ereno ^a   Dias, Amanda Latércia Tranches ^a   Gambale, Walderez ^a   Paula, Claudete Rodrigues ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EXOENZYME; FUNGAL ENZYME; PHOSPHOLIPASE; PROTEINASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; ENZYME SYNTHESIS; FUNGAL STRAIN; FUNGAL VIRULENCE; INOCULATION; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CENTRAL NERVOUS SYSTEM; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; MALE; MICE; MICE, INBRED BALB C; PEPTIDE HYDROLASES; PHOSPHOLIPASES; VIRULENCE;

EID: 32044475414     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46206-0     Document Type: Article

References (32)

1. Altman, D. G. (1997). Practical Statistics for Medical Research. London: Chapman & Hall.
2. Aoki, S., Ito-Kuma, S., Nakamura, K., Kato, J., Ninomiya, K. & Vidotto, V. (1994). Extracellular proteolytic activity of Cryptococcus neoformans. Mycopathologia 128, 143-150.
3. Baroni, F. de A. (2001). Ocorrência de Cryptococcus neoformans em excretas de pombos localizadas em torres de igrejas na cidade do Rio de Janeiro: fatores de virulência e sensibilidade aos antifungicos. Doctoral thesis, Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, Brazil (in Portuguese).
4. Barreto de Oliveira, M. T., Boekhout, T., Theelen, B. & 7 other authors (2004). Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. J Clin Microbiol 42, 1356-1359.
5. Brueske, C. H. (1986). Proteolytic activity of a clinical isolate of Cryptococcus neoformans. J Clin Microbiol 23, 631-633.
6. Buchanan, K. L. & Murphy, J. W. (1998). What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 4, 71-83.
7. Casadevall, A. & Perfect, J. R. (1998). Cryptococcus neoformans. Washington, DC: American Society for Microbiology.
8. Chen, S. C., Muller, M., Zhou, J. Z., Wright, L. C. & Sorrel, T. C. (1997). Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis 175, 414-420.
9. Cox, G. M., McDade, H. C., Chen, S. C. A. & 8 other authors (2001). Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39, 166-175.
10. Dias, A. L. T., Matsumoto, F. E., Melhem, M. S. C., Costa, S. O. P., Sigueria, A. M. & Paula, C. R. (2003). Evaluation of broth microdilution method for susceptibility testing of Brazilian clinical and environmental Cryptococcus neoformans isolates to five antifungal drugs. In Trends in Medical Mycology, pp. 123-125. Proceedings of the 9th Congress of the European Confederation of Medical Mycology and 7th Trends in Invasive Fungal Infections, Amsterdam, 28 September-1 October 2003. Bologna: Monduzzi Editore.
11. Doering, T. L., Nosanchunk, J. D., Roberts, W. K. & Casadevall, A. (1999). Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol 37, 175-181.
12. Franzot, S. P., Mukherjee, J., Cherniak, R., Chen, L.-C., Hamdan, J. S. & Casadevall, A. (1998). Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66, 89-97.
13. Franzot, S. P., Salkin, I. F. & Casadevall, A. (1999). Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 37, 838-840.
14. Ghannoum, M. A. (2000). Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13, 122-143.
15. Huerfano, S., Cepero, M. C. & Castaneda, E. (2003). Phenotype characterization of environmental Cryptococcus neoformans isolates. Biomedica 23, 328-340 (in Spanish).
16. Ikeda, R., Shinoda, T., Fukazawa, Y. & Kaufman, L. (1982). Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 16, 22-29.
17. Kurtzman, C. P. & Fell, J. W. (editors) (1998). The Yeasts: a Taxonomic Study. New York: Elsevier.
18. Lacaz, C. S., Porto, E., Martins, J. E. C., Vaccari-Heins, E. M. & De Melo, N. T. (2002). Tratado de Micologia Médica. São Paulo: Sarvier (in Portuguese).
19. Liu, L., Wakamatsu, K., Ito, S. & Williamson, P. R. (1999). Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformam during neuropathogenesis in mice. Infect Immun 67, 108-112.
20. Montenegro, H. & Paula, C. R. (2000). Environmental isolation of Cryptococcus neoformans var. gattii and C. neoformans var. neoformans in the city of São Paulo, Brazil. Med Mycol 38, 385-390.
21. Noverr, M. C., Cox, G. M., Perfect, J. R. & Huffnagle, G. B. (2003). Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 71, 1538-1547.
22. Noverr, M. C., Williamson, P. R., Fajardo, R. S. & Huffnagle, G. B. (2004). CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun 72, 1693-1699.
23. Olszewski, M. A., Noverr, M. C., Chen, G.-H., Toews, G. B., Cox, G. M., Perfect, J. R. & Huffnagle, G. B. (2004). Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 164, 1761-1771.
24. Pappalardo, M. C. S. M. & Melhem, M. S. C. (2003). Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop Sao Paulo 45, 299-305.
25. Price, M. F., Wilkinson, I. D. & Gentry, L. O. (1982). Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20, 7-14.
26. Ruchel, R., Tegeler, R. & Trost, M. (1982). A comparison of secretory proteinases from different strains of Candida albicans. Sabouraudia 20, 233-244.
27. Santangelo, R. T., Nouri-Sorkhabi, M. H., Sorrel, T. C., Cagney, M., Chen, S. C., Kuchel, P. W. & Wright, L C. (1999). Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol 48, 731-740.
28. Santangelo, R., Zoellner, H., Sorrel, T., Wilson, C., Donald, C., Djordjevic, J., Shounan, Y. & Wright, L. (2004). Role of extracellular phospholipases and mononuclear phagocytes in dissemination of Cryptococcosis in a murine model. Infect Immun 72, 2229-2239.
29. Steenbergen, J. N. & Casadevall, A. (2003). The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 5, 667-675.
30. Vidotto, V., Koga-Ito, C. Y., Canella, D., Sinicco, A., Di Perri, G., Aoki, S. & Ito-Kuwa, S. (2000). Extracellular activity in Cryptococcus neoformans strains isolated from AIDS patients and from environmental sources. Rev Iberoam Micol 17, 14-19.
31. Vidotto, V., Melhem, M., Pukinskas, S., Aoki, S., Carrara, C. & Pugliese, A. (2005). Extracellular enzymatic activity and serotype of Cryptococcus neoformans strains isolated from AIDS patients in Brazil. Rev Iberoam Micol 22, 29-33.
32. Zhu, X., Gibbons, J., Garcia-Rivera, J., Casadevall, A. & Williamson, P. R. (2001). Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect Immun 69, 5589-5596.